UroToday16h
ASCO 2024: Blood-Based Markers of Differential Efficacy of Bipolar Androgen Therapy and Enzalutamide in the Randomized TRANSFORMER Trial
(UroToday.com) The 2024 American Society of Clinical Oncology (ASCO) annual meeting held in Chicago, IL between May 31 and June 4 was host to the Rapid Oral Abstract Session: Genitourinary Cancer - ...
UroToday16h
SUO 2024: Implementing Smoking Cessation in the Urologic Oncology Setting
(UroToday.com) The 2024 SUO annual meeting included a session on smoking cessation, vaping, and e-cigarettes, featuring a presentation by Dr. Richard Matulewicz discussing implementing smoking ...
UroToday16h
SUO 2024: Heterogeneity of Intermediate Risk NMIBC
(UroToday.com) The 2024 SUO annual meeting included a session on non muscle invasive bladder cancer (NMIBC), featuring a presentation by Dr. Sima Porten discussing the heterogeneity of intermediate ...
UroToday18h
SUO 2024: Adjuvant Radiation Following Cystectomy: Underutilized Therapy?
(UroToday.com) The 2024 Society of Urologic Oncology (SUO) annual meeting held in Dallas, TX was host to an Advanced Disease and Adjuvant Therapy session. Dr. Omar Mian discussed the role of adjuvant ...
UroToday3d
Bipolar Androgen Therapy: Rationale, Candidate Patients, and Latest Evidence for mCRPC Patients
Androgen receptor inhibition remains the mainstay treatment of advanced prostate cancer. However, therapeutic resistance to androgen receptor inhibition is almost universal. Prostate cancer cells can ...
UroToday4d
Risk Factors and Contemporary Management Options for Pain and Discomfort Experienced During a Prostate Biopsy - Beyond the Abstract
Advances in imaging interpretation have led to more accurate risk stratification for men being diagnosed with prostate cancer (PCa). A significant number of men are diagnosed with low-risk prostate ...
UroToday4d
Antibiotic therapy for treating overactive bladder is not supported by clinical evidence.
A number of reports have suggested that the use of prolonged antibiotic treatment could be an effective therapy for patients with overactive bladder (OAB); however, this approach is contrary to ...
UroToday4d
Risk factors, urodynamic characteristics, and distress associated with nocturnal enuresis in overactive bladder -wet women.
Patients with overactive bladder syndrome-wet (OAB-wet) experience urgency urinary incontinence, particularly urinary frequency and nocturia. Nocturnal enuresis (NE) is less addressed among OAB-wet ...
UroToday4d
The Association Between Anthropometric Indices and Overactive Bladder (OAB): A Cross-Sectional Study From the NHANES 2005-2018.
The association between different anthropometric indices, including body mass index (BMI), a body shape index (ABSI), lipid accumulation product (LAP), visceral adiposity index (VAI), waist ...
UroToday4d
Health-promoting lifestyles and influencing factors among pregnant women with urinary incontinence: a multicentre cross-sectional study.
Lifestyle modification is an important part of non-surgical treatment for urinary incontinence (UI) and is strongly recommended. This study aims to explore the status and influencing factors of health ...
UroToday4d
Metastasis-directed therapy in oligometastatic and oligoprogressive renal cell carcinoma.
This review addresses the evolving role of metastasis-directed therapy (MDT) in the management of oligometastatic and oligoprogressive renal cell carcinoma (RCC). With advances in both surgical ...
UroToday4d
Associated factors and quality of life in women with urinary incontinence in southern Peru, 2023.
Urinary incontinence (UI), which can be classified as stress, urgency, or mixed, represents a public health problem that mainly affects adult women. This study aimed to determine the prevalence, ...